VThunter
a database for single-cell screening of virus target cells in animal kingdom
Mongolian horse

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Perissodactyla; Equidae; Equus; Equus,

Latin Name: Equus caballus

Tested tissues: PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0066 2021.04 iDrop PBMC Normal 12794 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Dengue virus
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
PBMC-Macrophage : 6.40% ;
PBMC-Neutrophil : 0.52% ;
PBMC-T cells : 0.12% ;
PBMC-B cells : 0.10% ;
PBMC-NK : 0.00% ;
PBMC-T cells : 0.36% ;
PBMC-Cycling_T : 0.00% ;
PBMC-Macrophage : 0.00% ;
Sindbis virus
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
Classical swine fever virus
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
Adeno-associated virus - 2
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-NK : 8.70% ;
PBMC-T cells : 6.19% ;
PBMC-B cells : 3.87% ;
PBMC-Macrophage : 2.91% ;
PBMC-Neutrophil : 1.43% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 5.71% ;
PBMC-Macrophage : 5.23% ;
PBMC-T cells : 4.87% ;
PBMC-Cycling_T : 1.59% ;
Adeno-associated virus 9
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
Adeno-associated virus - 8
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
Adeno-associated virus - 3
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
Venezuelan equine encephalitis virus
PBMC-T cells : 90.44% ;
PBMC-NK : 86.96% ;
PBMC-B cells : 84.24% ;
PBMC-Macrophage : 83.72% ;
PBMC-Cycling_T : 52.38% ;
Feline immunodeficiency virus
PBMC-T cells : 87.13% ;
PBMC-Macrophage : 84.88% ;
PBMC-NK : 68.12% ;
PBMC-B cells : 53.09% ;
PBMC-Neutrophil : 48.52% ;
PBMC-T cells : 22.97% ;
PBMC-Macrophage : 19.19% ;
PBMC-NK : 8.70% ;
PBMC-Cycling_T : 7.94% ;
PBMC-B cells : 1.84% ;
Human immunodeficiency virus 2
PBMC-T cells : 87.13% ;
PBMC-Macrophage : 84.88% ;
PBMC-NK : 68.12% ;
PBMC-B cells : 53.09% ;
PBMC-Neutrophil : 48.52% ;
PBMC-T cells : 18.76% ;
PBMC-Macrophage : 18.60% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 1.45% ;
PBMC-NK : 1.45% ;
Human immunodeficiency virus 1
PBMC-T cells : 87.13% ;
PBMC-Macrophage : 84.88% ;
PBMC-NK : 68.12% ;
PBMC-B cells : 53.09% ;
PBMC-Neutrophil : 48.52% ;
PBMC-T cells : 18.76% ;
PBMC-Macrophage : 18.60% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 1.45% ;
PBMC-NK : 1.45% ;
PBMC-NK : 8.70% ;
PBMC-Macrophage : 6.40% ;
PBMC-T cells : 5.29% ;
PBMC-Cycling_T : 3.17% ;
PBMC-B cells : 1.55% ;
Influenza A virus
PBMC-Macrophage : 82.56% ;
PBMC-Neutrophil : 51.48% ;
PBMC-B cells : 16.44% ;
PBMC-Cycling_T : 15.87% ;
PBMC-T cells : 13.05% ;
PBMC-Macrophage : 21.51% ;
PBMC-B cells : 20.12% ;
PBMC-NK : 15.94% ;
PBMC-T cells : 8.96% ;
PBMC-Cycling_T : 6.35% ;
PBMC-Macrophage : 0.58% ;
PBMC-T cells : 0.12% ;
PBMC-B cells : 0.10% ;
PBMC-Cycling_T : 0.00% ;
Lassa mammarenavirus
PBMC-Macrophage : 79.65% ;
PBMC-NK : 33.33% ;
PBMC-T cells : 33.25% ;
PBMC-B cells : 31.91% ;
PBMC-Cycling_T : 22.22% ;
PBMC-Cycling_T : 4.76% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.61% ;
PBMC-B cells : 2.22% ;
PBMC-Macrophage : 1.16% ;
PBMC-T cells : 0.36% ;
Simian rotavirus A strain RRV
PBMC-NK : 76.81% ;
PBMC-Macrophage : 73.26% ;
PBMC-T cells : 72.58% ;
PBMC-B cells : 67.02% ;
PBMC-Cycling_T : 46.03% ;
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-Macrophage : 7.56% ;
PBMC-Cycling_T : 3.17% ;
PBMC-T cells : 0.78% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
PBMC-T cells : 2.04% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
PBMC-Cycling_T : 0.00% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
PBMC-NK : 0.00% ;
Human alphaherpesvirus 1
PBMC-Macrophage : 57.56% ;
PBMC-T cells : 27.00% ;
PBMC-Neutrophil : 22.28% ;
PBMC-NK : 21.74% ;
PBMC-Cycling_T : 17.46% ;
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-Macrophage : 1.74% ;
PBMC-Neutrophil : 0.38% ;
PBMC-B cells : 0.10% ;
PBMC-T cells : 0.06% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.06% ;
PBMC-NK : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Human alphaherpesvirus 2
PBMC-Macrophage : 57.56% ;
PBMC-T cells : 27.00% ;
PBMC-Neutrophil : 22.28% ;
PBMC-NK : 21.74% ;
PBMC-Cycling_T : 17.46% ;
PBMC-Macrophage : 1.74% ;
PBMC-Neutrophil : 0.38% ;
PBMC-B cells : 0.10% ;
PBMC-T cells : 0.06% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.06% ;
PBMC-Cycling_T : 0.00% ;
PBMC-Macrophage : 0.00% ;
Rhinovirus B14
PBMC-Macrophage : 56.98% ;
PBMC-Neutrophil : 5.92% ;
PBMC-B cells : 2.80% ;
PBMC-T cells : 1.92% ;
PBMC-NK : 1.45% ;
Coxsackievirus A21
PBMC-Macrophage : 56.98% ;
PBMC-Neutrophil : 5.92% ;
PBMC-B cells : 2.80% ;
PBMC-T cells : 1.92% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-NK : 0.00% ;
Ebola virus
PBMC-B cells : 55.51% ;
PBMC-Macrophage : 23.84% ;
PBMC-Cycling_T : 9.52% ;
PBMC-T cells : 8.90% ;
PBMC-NK : 8.70% ;
PBMC-Macrophage : 4.65% ;
PBMC-Neutrophil : 0.72% ;
PBMC-B cells : 0.68% ;
PBMC-T cells : 0.12% ;
PBMC-Cycling_T : 0.00% ;
PBMC-T cells : 0.36% ;
Hepacivirus C
PBMC-Macrophage : 52.91% ;
PBMC-B cells : 33.17% ;
PBMC-NK : 30.43% ;
PBMC-T cells : 29.10% ;
PBMC-Cycling_T : 7.94% ;
PBMC-Macrophage : 50.58% ;
PBMC-Neutrophil : 17.18% ;
PBMC-NK : 11.59% ;
PBMC-Cycling_T : 7.94% ;
PBMC-T cells : 6.19% ;
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
PBMC-Macrophage : 23.84% ;
PBMC-B cells : 20.31% ;
PBMC-Cycling_T : 7.94% ;
PBMC-T cells : 7.82% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 0.77% ;
PBMC-Macrophage : 0.58% ;
PBMC-T cells : 0.24% ;
PBMC-NK : 0.00% ;
PBMC-B cells : 0.29% ;
PBMC-T cells : 0.12% ;
PBMC-NK : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Vesicular stomatitis virus
PBMC-Macrophage : 50.58% ;
PBMC-Neutrophil : 17.18% ;
PBMC-NK : 11.59% ;
PBMC-Cycling_T : 7.94% ;
PBMC-T cells : 6.19% ;
PBMC-Macrophage : 21.51% ;
PBMC-B cells : 20.12% ;
PBMC-NK : 15.94% ;
PBMC-T cells : 8.96% ;
PBMC-Cycling_T : 6.35% ;
Human rhinovirus A2
PBMC-Macrophage : 50.58% ;
PBMC-Neutrophil : 17.18% ;
PBMC-NK : 11.59% ;
PBMC-Cycling_T : 7.94% ;
PBMC-T cells : 6.19% ;
Equid alphaherpesvirus 1
PBMC-NK : 49.28% ;
PBMC-T cells : 46.24% ;
PBMC-Macrophage : 41.28% ;
PBMC-Neutrophil : 29.25% ;
PBMC-Cycling_T : 25.40% ;
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
Feline leukemia virus strain B/lambda-B1
PBMC-Macrophage : 48.84% ;
PBMC-B cells : 34.43% ;
PBMC-T cells : 23.09% ;
PBMC-NK : 20.29% ;
PBMC-Cycling_T : 15.87% ;
PBMC-B cells : 1.93% ;
PBMC-T cells : 1.86% ;
PBMC-Cycling_T : 1.59% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.52% ;
Simian sarcoma-associated virus
PBMC-Macrophage : 48.84% ;
PBMC-B cells : 34.43% ;
PBMC-T cells : 23.09% ;
PBMC-NK : 20.29% ;
PBMC-Cycling_T : 15.87% ;
Gibbon ape leukemia virus
PBMC-Macrophage : 48.84% ;
PBMC-B cells : 34.43% ;
PBMC-T cells : 23.09% ;
PBMC-NK : 20.29% ;
PBMC-Cycling_T : 15.87% ;
PBMC-B cells : 1.93% ;
PBMC-T cells : 1.86% ;
PBMC-Cycling_T : 1.59% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.52% ;
Human mastadenovirus B
PBMC-Macrophage : 48.26% ;
PBMC-B cells : 6.29% ;
PBMC-NK : 5.80% ;
PBMC-Neutrophil : 3.82% ;
PBMC-Cycling_T : 1.59% ;
PBMC-NK : 7.25% ;
PBMC-Macrophage : 6.40% ;
PBMC-Cycling_T : 4.76% ;
PBMC-T cells : 4.45% ;
PBMC-B cells : 2.42% ;
Human parvovirus B19
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-NK : 8.70% ;
PBMC-T cells : 6.19% ;
PBMC-B cells : 3.87% ;
PBMC-Macrophage : 2.91% ;
PBMC-Neutrophil : 1.43% ;
Foot-and-mouth disease virus
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-NK : 8.70% ;
PBMC-T cells : 6.19% ;
PBMC-B cells : 3.87% ;
PBMC-Macrophage : 2.91% ;
PBMC-Neutrophil : 1.43% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
PBMC-Cycling_T : 0.00% ;
Mammalian orthoreovirus
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-Macrophage : 7.56% ;
PBMC-Cycling_T : 3.17% ;
PBMC-T cells : 0.78% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
Human metapneumovirus
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-NK : 8.70% ;
PBMC-T cells : 6.19% ;
PBMC-B cells : 3.87% ;
PBMC-Macrophage : 2.91% ;
PBMC-Neutrophil : 1.43% ;
Human betaherpesvirus 5
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
Human rotavirus strain WA
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-Macrophage : 7.56% ;
PBMC-Cycling_T : 3.17% ;
PBMC-T cells : 0.78% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
PBMC-T cells : 2.04% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
Human gammaherpesvirus 4
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
Echovirus E8
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-T cells : 2.04% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
Echovirus E1
PBMC-Macrophage : 43.02% ;
PBMC-NK : 42.03% ;
PBMC-T cells : 29.22% ;
PBMC-Cycling_T : 20.63% ;
PBMC-B cells : 17.50% ;
PBMC-T cells : 2.04% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
Bovine leukemia virus
PBMC-Macrophage : 41.86% ;
PBMC-B cells : 25.73% ;
PBMC-Cycling_T : 25.40% ;
PBMC-T cells : 23.93% ;
PBMC-NK : 20.29% ;
Mouse mammary tumor virus
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
Argentinian mammarenavirus
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
Canine parvovirus
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
Feline panleukopenia virus
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
Guanarito mammarenavirus
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
Severe acute respiratory syndrome coronavirus 2
PBMC-Macrophage : 36.63% ;
PBMC-NK : 2.90% ;
PBMC-T cells : 0.60% ;
PBMC-Neutrophil : 0.43% ;
PBMC-B cells : 0.10% ;
PBMC-Macrophage : 23.84% ;
PBMC-B cells : 20.31% ;
PBMC-Cycling_T : 7.94% ;
PBMC-T cells : 7.82% ;
PBMC-NK : 7.25% ;
Machupo mammarenavirus
PBMC-Macrophage : 36.63% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.93% ;
PBMC-T cells : 3.73% ;
PBMC-NK : 2.90% ;
Simian type D retrovirus -Tsukuba
PBMC-Macrophage : 30.81% ;
PBMC-B cells : 27.95% ;
PBMC-Cycling_T : 6.35% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.67% ;
Feline endogenous virus RD114
PBMC-Macrophage : 30.81% ;
PBMC-B cells : 27.95% ;
PBMC-Cycling_T : 6.35% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.67% ;
Baboon endogenous virus strain M7
PBMC-Macrophage : 30.81% ;
PBMC-B cells : 27.95% ;
PBMC-Cycling_T : 6.35% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.67% ;
Enterovirus A71
PBMC-NK : 27.54% ;
PBMC-Macrophage : 18.02% ;
PBMC-T cells : 9.56% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.26% ;
PBMC-Macrophage : 23.26% ;
PBMC-T cells : 7.52% ;
PBMC-NK : 4.35% ;
PBMC-Neutrophil : 4.15% ;
PBMC-Cycling_T : 3.17% ;
Coxsackievirus A16
PBMC-NK : 27.54% ;
PBMC-Macrophage : 18.02% ;
PBMC-T cells : 9.56% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 4.26% ;
Human betaherpesvirus 6B
PBMC-T cells : 22.97% ;
PBMC-Macrophage : 19.19% ;
PBMC-NK : 8.70% ;
PBMC-Cycling_T : 7.94% ;
PBMC-B cells : 1.84% ;
Feline leukemia virus strain C/FA27
PBMC-B cells : 22.15% ;
PBMC-Macrophage : 16.86% ;
PBMC-T cells : 9.68% ;
PBMC-NK : 8.70% ;
PBMC-Cycling_T : 7.94% ;
Enterovirus B
PBMC-Macrophage : 22.09% ;
PBMC-T cells : 1.68% ;
PBMC-Cycling_T : 1.59% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 0.77% ;
Porcine endogenous retrovirus A
PBMC-NK : 20.29% ;
PBMC-Cycling_T : 15.87% ;
PBMC-T cells : 8.12% ;
PBMC-Macrophage : 7.56% ;
PBMC-B cells : 5.03% ;
Simian immunodeficiency virus
PBMC-T cells : 18.76% ;
PBMC-Macrophage : 18.60% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 1.45% ;
PBMC-NK : 1.45% ;
PBMC-NK : 8.70% ;
PBMC-Macrophage : 6.40% ;
PBMC-T cells : 5.29% ;
PBMC-Cycling_T : 3.17% ;
PBMC-B cells : 1.55% ;
Human betaherpesvirus 7
PBMC-T cells : 18.76% ;
PBMC-Macrophage : 18.60% ;
PBMC-Cycling_T : 6.35% ;
PBMC-B cells : 1.45% ;
PBMC-NK : 1.45% ;
Porcine reproductive and respiratory syndrome virus
PBMC-Macrophage : 18.60% ;
PBMC-NK : 4.35% ;
PBMC-B cells : 3.48% ;
PBMC-Cycling_T : 1.59% ;
PBMC-Neutrophil : 1.15% ;
PBMC-Macrophage : 8.14% ;
PBMC-T cells : 0.12% ;
PBMC-B cells : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Human papillomavirus type 16
PBMC-Macrophage : 18.60% ;
PBMC-NK : 4.35% ;
PBMC-B cells : 3.48% ;
PBMC-Cycling_T : 1.59% ;
PBMC-Neutrophil : 1.15% ;
PBMC-Macrophage : 0.58% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Xenotropic murine leukemia virus
PBMC-Macrophage : 14.53% ;
PBMC-B cells : 7.06% ;
PBMC-Cycling_T : 6.35% ;
PBMC-T cells : 5.23% ;
PBMC-NK : 1.45% ;
Polytropic murine leukemia virus
PBMC-Macrophage : 14.53% ;
PBMC-B cells : 7.06% ;
PBMC-Cycling_T : 6.35% ;
PBMC-T cells : 5.23% ;
PBMC-NK : 1.45% ;
Ecotropic murine leukemia virus
PBMC-Macrophage : 13.95% ;
PBMC-B cells : 9.19% ;
PBMC-NK : 5.80% ;
PBMC-T cells : 1.86% ;
PBMC-Cycling_T : 1.59% ;
Human alphaherpesvirus 3
PBMC-NK : 13.04% ;
PBMC-B cells : 12.67% ;
PBMC-Cycling_T : 9.52% ;
PBMC-Macrophage : 6.98% ;
PBMC-T cells : 5.89% ;
Varicella Zoster Virus
PBMC-NK : 13.04% ;
PBMC-B cells : 12.67% ;
PBMC-Cycling_T : 9.52% ;
PBMC-Macrophage : 6.98% ;
PBMC-T cells : 5.89% ;
Suid alphaherpesvirus 1
PBMC-Macrophage : 12.21% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.18% ;
PBMC-Neutrophil : 0.05% ;
PBMC-Cycling_T : 0.00% ;
PBMC-Macrophage : 1.74% ;
PBMC-Neutrophil : 0.38% ;
PBMC-B cells : 0.10% ;
PBMC-T cells : 0.06% ;
PBMC-NK : 0.00% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.06% ;
Bovine alphaherpesvirus 1
PBMC-Macrophage : 12.21% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.18% ;
PBMC-Neutrophil : 0.05% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.06% ;
PBMC-NK : 0.00% ;
Enterovirus C
PBMC-Macrophage : 12.21% ;
PBMC-B cells : 0.19% ;
PBMC-T cells : 0.18% ;
PBMC-Neutrophil : 0.05% ;
Middle East respiratory syndrome-related coronavirus
PBMC-T cells : 11.43% ;
PBMC-NK : 8.70% ;
PBMC-Cycling_T : 7.94% ;
PBMC-Macrophage : 5.81% ;
PBMC-B cells : 4.84% ;
Chikungunya virus
PBMC-Macrophage : 10.47% ;
PBMC-Cycling_T : 6.35% ;
PBMC-T cells : 2.59% ;
PBMC-B cells : 2.13% ;
PBMC-NK : 1.45% ;
PBMC-T cells : 0.36% ;
PBMC-Neutrophil : 0.00% ;
Coxsackievirus A9
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
PBMC-Cycling_T : 0.00% ;
Human mastadenovirus C
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-Macrophage : 6.40% ;
PBMC-T cells : 0.06% ;
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Human parechovirus 1
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
Coxsackievirus B1
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
West Nile virus
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
PBMC-NK : 0.00% ;
Human gammaherpesvirus 8
PBMC-Macrophage : 9.30% ;
PBMC-T cells : 8.42% ;
PBMC-NK : 7.25% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 0.62% ;
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
PBMC-Cycling_T : 0.00% ;
PBMC-B cells : 0.10% ;
PBMC-T cells : 0.06% ;
PBMC-NK : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Echovirus E6
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-NK : 0.00% ;
Echovirus E12
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
Echovirus E33
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-NK : 0.00% ;
Human enterovirus 70
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-NK : 0.00% ;
Coxsackievirus B3
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Echovirus E7
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Echovirus E29
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Echovirus E11
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Enterovirus D68
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Echovirus E21
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Echovirus E20
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Cycling_T : 0.00% ;
Coxsackievirus B5
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Echovirus E13
PBMC-B cells : 9.09% ;
PBMC-Neutrophil : 6.92% ;
PBMC-Macrophage : 4.65% ;
PBMC-T cells : 0.24% ;
Feline calicivirus
PBMC-Macrophage : 7.56% ;
PBMC-Cycling_T : 3.17% ;
PBMC-T cells : 0.78% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
Encephalomyocarditis virus
PBMC-Macrophage : 6.40% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.14% ;
PBMC-T cells : 0.12% ;
PBMC-Cycling_T : 0.00% ;
Rinderpest morbillivirus
PBMC-T cells : 6.01% ;
PBMC-B cells : 4.93% ;
PBMC-Cycling_T : 3.17% ;
PBMC-NK : 2.90% ;
PBMC-Macrophage : 2.33% ;
Phocine morbillivirus
PBMC-T cells : 6.01% ;
PBMC-B cells : 4.93% ;
PBMC-Cycling_T : 3.17% ;
PBMC-NK : 2.90% ;
PBMC-Macrophage : 2.33% ;
Measles morbillivirus
PBMC-T cells : 6.01% ;
PBMC-B cells : 4.93% ;
PBMC-Cycling_T : 3.17% ;
PBMC-NK : 2.90% ;
PBMC-Macrophage : 2.33% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.10% ;
PBMC-NK : 0.00% ;
Canine morbillivirus
PBMC-T cells : 6.01% ;
PBMC-B cells : 4.93% ;
PBMC-Cycling_T : 3.17% ;
PBMC-NK : 2.90% ;
PBMC-Macrophage : 2.33% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.10% ;
PBMC-T cells : 0.00% ;
PBMC-Cycling_T : 0.00% ;
Jaagsiekte sheep retrovirus
PBMC-Macrophage : 5.23% ;
PBMC-B cells : 4.45% ;
PBMC-T cells : 2.59% ;
PBMC-Neutrophil : 0.10% ;
PBMC-Cycling_T : 0.00% ;
Latino mammarenavirus
PBMC-Cycling_T : 4.76% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.61% ;
PBMC-B cells : 2.22% ;
PBMC-Macrophage : 1.16% ;
Oliveros mammarenavirus
PBMC-Cycling_T : 4.76% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.61% ;
PBMC-B cells : 2.22% ;
PBMC-Macrophage : 1.16% ;
Lymphocytic choriomeningitis mammarenavirus
PBMC-Cycling_T : 4.76% ;
PBMC-NK : 4.35% ;
PBMC-T cells : 3.61% ;
PBMC-B cells : 2.22% ;
PBMC-Macrophage : 1.16% ;
PBMC-T cells : 0.36% ;
PBMC-Cycling_T : 0.00% ;
PBMC-Macrophage : 0.00% ;
Marburg marburgvirus
PBMC-Macrophage : 4.65% ;
PBMC-Neutrophil : 0.72% ;
PBMC-B cells : 0.68% ;
PBMC-T cells : 0.12% ;
PBMC-NK : 0.00% ;
PBMC-T cells : 0.36% ;
Coxsackievirus B2
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Human mastadenovirus D
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Coxsackievirus B6
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Human mastadenovirus A
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Human mastadenovirus F
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Human mastadenovirus E
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Coxsackievirus B4
PBMC-Macrophage : 2.91% ;
PBMC-Cycling_T : 1.59% ;
PBMC-B cells : 0.87% ;
PBMC-T cells : 0.42% ;
PBMC-Neutrophil : 0.10% ;
Respiratory syncytial virus
PBMC-NK : 2.90% ;
PBMC-T cells : 1.20% ;
PBMC-Macrophage : 1.16% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
Rabies lyssavirus
PBMC-Macrophage : 2.33% ;
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.05% ;
PBMC-NK : 0.00% ;
PBMC-B cells : 0.39% ;
PBMC-Neutrophil : 0.00% ;
Hepatitis E virus
PBMC-T cells : 1.98% ;
PBMC-Cycling_T : 1.59% ;
PBMC-NK : 1.45% ;
PBMC-Neutrophil : 0.05% ;
Amphotropic murine leukemia virus
PBMC-B cells : 1.93% ;
PBMC-T cells : 1.86% ;
PBMC-Cycling_T : 1.59% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.52% ;
Hendra henipavirus
PBMC-Cycling_T : 1.59% ;
PBMC-NK : 1.45% ;
PBMC-T cells : 1.38% ;
PBMC-Macrophage : 1.16% ;
PBMC-B cells : 0.10% ;
PBMC-T cells : 0.54% ;
PBMC-B cells : 0.29% ;
PBMC-Neutrophil : 0.10% ;
PBMC-NK : 0.00% ;
Nipah henipavirus
PBMC-Cycling_T : 1.59% ;
PBMC-NK : 1.45% ;
PBMC-T cells : 1.38% ;
PBMC-Macrophage : 1.16% ;
PBMC-B cells : 0.10% ;
PBMC-T cells : 0.54% ;
PBMC-B cells : 0.29% ;
PBMC-Neutrophil : 0.10% ;
PBMC-NK : 0.00% ;
Hepatitis delta virus
PBMC-Cycling_T : 1.59% ;
PBMC-NK : 1.45% ;
PBMC-B cells : 1.35% ;
PBMC-Neutrophil : 1.24% ;
PBMC-Macrophage : 0.58% ;
Hantaan orthohantavirus
PBMC-T cells : 0.96% ;
PBMC-Macrophage : 0.58% ;
PBMC-Neutrophil : 0.14% ;
PBMC-B cells : 0.10% ;
PBMC-Cycling_T : 0.00% ;
Coxsackievirus A10
PBMC-Macrophage : 0.58% ;
PBMC-T cells : 0.06% ;
Mayaro virus
PBMC-T cells : 0.36% ;
PBMC-Cycling_T : 0.00% ;
PBMC-Macrophage : 0.00% ;
Ross River virus
PBMC-T cells : 0.36% ;
Zika virus
PBMC-T cells : 0.36% ;
PBMC-NK : 0.00% ;
PBMC-B cells : 0.00% ;
PBMC-Neutrophil : 0.00% ;
Onyong-nyong virus
PBMC-T cells : 0.36% ;
PBMC-Macrophage : 0.00% ;
Small ruminant morbillivirus
PBMC-B cells : 0.19% ;
PBMC-Neutrophil : 0.10% ;
PBMC-T cells : 0.00% ;
PBMC-Cycling_T : 0.00% ;
Rhinovirus C
PBMC-Neutrophil : 0.05% ;
PBMC-NK : 0.00% ;
PBMC-B cells : 0.00% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China